AFG
IOVA icon

American Financial Group’s Iovance Biotherapeutics IOVA Stock Holding History

American Financial Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$598K – 127
2020
Q1 		$598K Hold
20,000
– – 0.07% 99
2019
Q4 		$554K Sell
20,000
-20,000
-50% -$455K 0.05% 101
2019
Q3 		$728K Hold
40,000
– – 0.06% 103
2019
Q2 		$980K Hold
40,000
– – 0.08% 99
2019
Q1 		$380K Hold
40,000
– – 0.03% 117
2018
Q4 		$354K Buy
40,000
+20,000
+100% +$193K 0.03% 119
2018
Q3 		$224K Buy
+20,000
New +$284K 0.02% 102

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

American Financial Group's IOVA Position: Q2 2020 in Review

American Financial Group sold out of Iovance Biotherapeutics (IOVA) in Q2 2020, closing a stake of 20,000 shares — an estimated $598K sold.

American Financial Group first reported a position in IOVA in Q3 2018 and held it in 7 quarters. The position peaked at $980K in Q2 2019. 257 funds tracked by Wall St. Rank hold IOVA as of Q2 2020.

  • American Financial Group reported no remaining Iovance Biotherapeutics position as of Q2 2020 after selling out during the quarter.
  • American Financial Group sold 20,000 Iovance Biotherapeutics shares in Q2 2020, an estimated $598K.
  • American Financial Group first reported a position in Iovance Biotherapeutics in Q3 2018 and held it in 7 quarters.
  • American Financial Group's Iovance Biotherapeutics position peaked at $980K in Q2 2019.
  • 257 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2020.

Based on American Financial Group's 13F filing for Q2 2020, filed 7 Aug 2020.